Addex Therapeutics and Indivior are partnering on a drug candidate.
3 reports, 1 independent
Updated Thu 00:00
No new developments lately
- Reports
- 3
- Developments
- 3
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Addex Therapeutics and Indivior are partnering on a drug candidate.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Indivior and Addex Therapeutics regained full global rights to GABAB PAM assets.Sub-event
The partnership between Indivior and Addex Therapeutics focuses on a GABAB PAM candidate.1 source
Partnership formed between Addex Therapeutics and Indivior regarding a drug candidate.1 source
Keep exploring
The entities involved
-
Indivior
specialty pharmaceuticals business headquartered in Richmond, Virginia
-
Addex Therapeutics
Swiss public company